首页|糖尿病神经性骨关节病的诊治进展

糖尿病神经性骨关节病的诊治进展

扫码查看
糖尿病神经性骨关节病是一种严重影响足踝关节的致残性疾病,早期表现不典型,常导致治疗延误,以往多采用完全减压和制动,对于药物治疗关注不足.从药理机制研究角度发现,地舒单抗可能对于治疗该病有一定的效果.本文综述了该病的研究和诊治进展,以及国外采用地舒单抗治疗糖尿病神经性骨关节病的研究报道,以期丰富对该病的诊疗方法.
Advances in the diagnosis and treatment of diabetic neuropathic osteoarthropathy
Diabetic neuropathic osteoarthropathy is a debilitating disease that seriously affects the foot and ankle joints,with atypical early manifestations that often lead to delayed treatment,in the past,complete decompression and braking have been used,with insufficient attention to pharmacological treat-ment.Research into pharmacological mechanisms has shown that denosumab may be effective in treating this disease.This article reviews the progress of research on the diagnosis and treatment of diabetic neurological osteoarthropathy.It also discusses foreign research reports on the use of denosumab in the treatment of dia-betic neurological osteoarthropathy.

DiabeticDiabetic neuropathic osteoarthropathyDenosumab

王毅、何岸苇、晁爱军

展开 >

天津市天津医院神经内科,天津 300211

天津市天津医院放射一科,天津 300211

天津市天津医院骨内科,天津 300211

糖尿病 神经性骨关节病 地舒单抗

2024

国际内分泌代谢杂志
中华医学会,天津医科大学

国际内分泌代谢杂志

CSTPCD
影响因子:0.842
ISSN:1673-4157
年,卷(期):2024.44(2)
  • 20